An announcement from Consun Pharmaceutical Group Ltd. ( (HK:1681) ) is now available.
Consun Pharmaceutical Group Ltd. has appointed Professor Jonathan Barratt as a scientific advisor, enhancing its expertise in renal medicine. Professor Barratt’s extensive experience in nephrology and his leadership in international research networks are expected to significantly contribute to the company’s long-term growth and development in the pharmaceutical sector.
More about Consun Pharmaceutical Group Ltd.
Consun Pharmaceutical Group Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is known for its commitment to advancing medical research and providing innovative healthcare solutions.
YTD Price Performance: -12.14%
Average Trading Volume: 1,371
Technical Sentiment Signal: Strong Sell
Current Market Cap: €877.1M
Find detailed analytics on 1681 stock on TipRanks’ Stock Analysis page.